請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/22314完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 沈立言(Lee-Yan Sheen) | |
| dc.contributor.author | Yu-Chun Lee | en |
| dc.contributor.author | 李侑純 | zh_TW |
| dc.date.accessioned | 2021-06-08T04:15:23Z | - |
| dc.date.copyright | 2010-08-09 | |
| dc.date.issued | 2010 | |
| dc.date.submitted | 2010-08-06 | |
| dc.identifier.citation | 蔡東湖。2007。大白鼠的基本手術技術與微透析應用。時新出版。台北。pp.31。
行政院衛生署統計室。2004-2008。死因統計。(http://www.bhp.doh.gov.tw /BHPnet /Portal/) 行政院衛生署。2003。健康食品之護肝功能評估方法 (針對化學性肝損傷)。(http:// www.doh.gov.tw/CHT2006/DM/DM2_p01.aspx?class_no=24&now_fod_list_no=9381&level_no=2&doc_no=22498) 譚健民。1999。肝功能異常時該怎麼辦。生智出版。台北。pp.10-40。 王啟華、邱學才、伍思琪、劉玲愛、張文光、田野蘋、李忠華、方少瑛。2002。 實用人體解剖生理學。合記書局有限公司。台北。pp.470-477。 魏正舒、鄭恩加、沈武訓、顏秀娟。2003。臨床化學：原理、步驟與關聯性。合記圖書出版社。台北。pp.353-365。 胡明一、陳懿慧、謝慧瑛、孫穆乾。2003。人體解剖學。藝軒圖書出版社。台北。 pp.402-405。 金惠民。2003。疾病、營養與膳食療養。華香園出版社。台北。pp.343-370。 章樂綺、殷梅津、蘭淑貞、歐陽鍾美、陳珮蓉、彭巧珍、穆懷玲、鄭金寶、楊雀 鑾、王麗民、林宜芬、張秋娥、藍潔。2004。實用營養學。偉華書局有限公 司。台北。pp.100-150。 蔡哲雄、陳昭姿。2001。對抗癌症系列（三）肝病三部曲。天下生活出版股份有 限公司。台北。pp.75-77。 施新獻。2000。現代醫學動物實驗學。北京人民軍醫出版社。pp.335。 Ahmad, F. F.; Cowan, D. L.; Sun, A. Y., Detection of free radical formation in various tissues after acute carbon tetrachloride administration in gerbil. Life Sci. 1987, 41, (22), 2469-2475. Aydin, A. F.; Kusku-Kiraz, Z.; Dogru-Abbasoglu, S.; Gulluoglu, M.; Uysal, M.; Kocak-Toker, N., Effect of carnosine against thioacetamide-induced liver cirrhosis in rat. Peptides. 2009, 31, (1), 67-71. Babior, B. M., Phagocytes and oxidative stress. Am J Med. 2000, 109, (1), 33-44. Bailey, S. A.; Zidell, R. H.; Perry, R. W., Relationships between organ weight and body/brain weight in the rat: what is the best analytical endpoint? Toxicol Pathol. 2004, 32, (4), 448-466. Bains, J. S.; Shaw, C. A., Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Brain Res Rev. 1997, 25, (3), 335-358. Baker, M. A.; Cerniglia, G. J.; Zaman, A., Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem. 1990, 190, (2), 360-365. Bataller, R.; Brenner, D. A., Liver fibrosis. J Clin Invest. 2005, 115, (2), 209-218. Bellomo, G.; Mirabelli, F.; DiMonte, D.; Richelmi, P.; Thor, H.; Orrenius, C.; Orrenius, S., Formation and reduction of glutathione-protein mixed disulfides during oxidative stress. A study with isolated hepatocytes and menadione (2-methyl-1,4-naphthoquinone). Biochem Pharmacol. 1987, 36, (8), 1313-1320. Begum, G.; Cunliffe, A.; Leveritt, M., Physiological role of carnosine in contracting muscle. Int J Sport Nutr Exerc Metab. 2005, 15, (5), 493-514. Benyon, R. C.; Iredale, J. P., Is liver fibrosis reversible? Gut. 2000, 46, (4), 443-446. Biggerstaff, K. D.; Wooten, J. S., Understanding lipoproteins as transporters of cholesterol and other lipids. Adv Physiol Educ. 2004, 28, (1-4), 105-106. Bissell, D. M.; Friedman, S. L.; Maher, J. J.; Roll, F. J., Connective tissue biology and hepatic fibrosis: report of a conference. Hepatology. 1990, 11, (3), 488-498. Boigk, G.; Stroedter, L.; Herbst, H.; Waldschmidt, J.; Riecken, E. O.; Schuppan, D., Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology. 1997, 26, (3), 643-649. Boldyrev, A.; Bulygina, E.; Leinsoo, T.; Petrushanko, I.; Tsubone, S.; Abe, H., Protection of neuronal cells against reactive oxygen species by carnosine and related compounds. Comp Biochem Physiol B Biochem Mol Biol. 2004, 137, (1), 81-88. Boll, M.; Weber, L. W.; Becker, E.; Stampfl, A., Pathogenesis of carbon tetrachloride-induced hepatocyte injury bioactivation of CCl4 by cytochrome P450 and effects on lipid homeostasis. Z Naturforsch C. 2001a, 56, (1-2), 111-121. Boll, M.; Weber, L. W.; Becker, E.; Stampfl, A., Hepatocyte damage induced by carbon tetrachloride: inhibited lipoprotein secretion and changed lipoprotein composition. Z Naturforsch C. 2001b, 56, (3-4), 283-290. Brattin, W. J.; Glende, E. A., Jr.; Recknagel, R. O., Pathological mechanisms in carbon tetrachloride hepatotoxicity. J Free Radic Biol Med. 1985, 1, (1), 27-38. Cai, H., Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc Res. 2005, 68, (1), 26-36. Candeias, L. P.; Patel, K. B.; Stratford, M. R.; Wardman, P., Free hydroxyl radicals are formed on reaction between the neutrophil-derived species superoxide anion and hypochlorous acid. FEBS Lett. 1993, 333, (1-2), 151-153. Candeias, L. P.; Stratford, M. R.; Wardman, P., Formation of hydroxyl radicals on reaction of hypochlorous acid with ferrocyanide, a model iron(II) complex. Free Radic Res. 1994, 20, (4), 241-249. Chan, D. C.; Barrett, P. H.; Watts, G. F., Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methods. Clin Sci (Lond). 2004, 107, (3), 233-249. Chan, Y. C.; Chang, S. C.; Liu, S. Y.; Yang, H. L.; Hseu, Y. C.; Liao, J. W., Beneficial effects of yam on carbon tetrachloride-induced hepatic fibrosis in rats. J Sci Food Agric 2010, 90, (1), 161-167. Chang, H. Y.; Peng, W. H.; Sheu, M. J.; Huang, G. J.; Tseng, M. C.; Lai, M. T.; Ho, Y. L.; Chang, Y. S., Hepatoprotective and Antioxidant Effects of Ethanol Extract from Phellinus merrillii on carbon tetrachloride-induced liver damage. Am J Chin Med. 2007, 35, (5), 793-804. Cheng, T. O., Panax (ginseng) is not a panacea. Arch Intern Med. 2000, 160, (21), 3329. Chen, Y.; Shertzer, H. G.; Schneider, S. N.; Nebert, D. W.; Dalton, T. P., Glutamate cysteine ligase catalysis: dependence on ATP and modifier subunit for regulation of tissue glutathione levels. J Biol Chem. 2005, 280, (40), 33766-33774. Chen, J.; Peng, H.; Ou-Yang, X.; He, X., Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells. Melanoma Res. 2008, 18, (5), 322-329. Csiszar, A.; Pacher, P.; Kaley, G.; Ungvari, Z., Role of oxidative and nitrosative stress, longevity genes and poly(ADP-ribose) polymerase in cardiovascular dysfunction associated with aging. Curr Vasc Pharmacol. 2005, 3, (3), 285-291. Curzio, M.; Esterbauer, H.; Dianzani, M. U., Chemotactic activity of hydroxyalkenals on rat neutrophils. Int J Tissue React. 1985, 7, (2), 137-142. Cuzzocrea, S.; Genovese, T.; Failla, M.; Vecchio, G.; Fruciano, M.; Mazzon, E.; Di Paola, R.; Muia, C.; La Rosa, C.; Crimi, N.; Rizzarelli, E.; Vancheri, C., Protective effect of orally administered carnosine on bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 2007, 292, (5), 1095-1104. Czaja, M. J.; Xu, J.; Alt, E., Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology. 1995, 108, (6), 1849-1854. Dehmlow, C.; Erhard, J.; de Groot, H., Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin. Hepatology. 1996, 23, (4), 749-754. Deneke, S. M.; Fanburg, B. L., Regulation of cellular glutathione. Am J Physiol. 1989, 257, (4 Pt 1), 163-173. Dickinson, D. A.; Forman, H. J., Glutathione in defense and signaling: lessons from a small thiol. Ann N Y Acad Sci. 2002a, 973, 488-504. Dickinson , D. A.; Forman, H. J., Cellular glutathione and thiols metabolism. Biochem Pharmacol. 2002b, 64, 1019-1026. Drake, J.; Kanski, J.; Varadarajan, S.; Tsoras, M.; Butterfield, D. A., Elevation of brain glutathione by gamma-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress. J Neurosci Res. 2002, 68, (6), 776-784. Ellman, G. L., A colorimetric method for determining low concentrations of mercaptans. Arch Biochem Biophys. 1958, 74, (2), 443-450. Eyer, P.; Podhradsky, D., Evaluation of the micromethod for determination of glutathione using enzymatic cycling and Ellman's reagent. Anal Biochem. 1986, 153, (1), 57-66. Evans, P.; Halliwell, B., Free radicals and hearing. Cause, consequence, and criteria. Ann N Y Acad Sci. 1999, 884, 19-40. Fang, Y. Z.; Yang, S.; Wu, G., Free radicals, antioxidants, and nutrition. Nutrition. 2002, 18, (10), 872-879. Flora, K.; Hahn, M.; Rosen, H.; Benner, K., Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol. 1998, 93, (2), 139-143. Fouad, A. A.; Qureshi, H. A.; Yacoubi, M. T.; Al-Melhim, W. N., Protective role of carnosine in mice with cadmium-induced acute hepatotoxicity. Food Chem Toxicol. 2009, 47, (11), 2863-2870. Friedman, S. L., Liver fibrosis -- from bench to bedside. J Hepatol. 2003, 38 Suppl 1, 38-53. Gilgun-Sherki, Y., Melamed, E., Offen, D., Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology. 2001, 40, 8, 959-975. Giorgio, M.; Trinei, M.; Migliaccio, E.; Pelicci, P. G., Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nat Rev Mol Cell Biol. 2007, 8, (9), 722-728. Griffith, O. W., Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem. 1980, 106, (1), 207-212. Gum, S. I.; Jo, S. J.; Ahn, S. H.; Kim, S. G.; Kim, J. T.; Shin, H. M.; Cho, M. K., The potent protective effect of wild ginseng (Panax ginseng C.A. Meyer) against benzo[alpha]pyrene-induced toxicity through metabolic regulation of CYP1A1 and GSTs. J Ethnopharmacol. 2007, 112, (3), 568-576. Harkness, E. J.; Wagner, J. E.; The biology and medicine of rabbits and rodents, 2nd ed, Philadelphia : Lea & Febiger, 1983, pp. 54-59. Habib, S. S., Lipoprotein(a). The bad cholesterol. Saudi Med J. 2004, 25, (4), 429-433. Habig, W. H.; Pabst, M. J.; Jakoby, W. B., Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974, 249, (22), 7130-7139. Halliwell, B.; Gutteridge, J. M. The importance of free radicals and catalytic metal ions in human diseases. Mol Aspects Med. 1985, 8, 2, 89-193. Halliwell, B.; Gutteridge, J. M.; Cross, C. E., Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med. 1992, 119, (6), 598-620. Halliwell, B.; Aeschbach, R.; Loliger, J.; Aruoma, O. I., The characterization of antioxidants. Food Chem Toxicol. 1995, 33, (7), 601-617. Hammarstrom, S., Metabolism of leukotriene C3 in the guinea pig. Identification of metabolites formed by lung, liver, and kidney. J Biol Chem. 1981, 256, (18), 9573-9578. Hanauske-Abel HM: Fibrosis of liver; representative molecular elements and their emerging role as anti-fibrotic targets. In: Hepatology: A Textbook of Liver Disease, 4th ed. (Zakim D, Boyer TD, eds.), W.B. Saunders, Philadelphia, 2003, pp. 347-394. Hers, H. G., Le Metabolisme du Fructose. Editions Arsia Bruxelles. 1957, pp. 200. Hers, H. G., Van Hoof, F. and de Barsy, T. The glycogen storage disease. In: Scriver, C. R., Beaudet, A. L., Sly W. S. and Valle, D. (eds.), The Metabolic Basis of Inherited Disease, 6 th edn., McGraw-Hill, New York, Vol. 1, 1989, pp. 425-452. Hers, H. G., Mechanisms of blood glucose homeostasis. J Inherit Metab Dis.1990, 13, (4), 395-410. Howard, R. B.; Christensen, A. K.; Gibbs, F. A.; Pesch, L. A., The enzymatic preparation of isolated intact parenchymal cells from rat liver. J Cell Biol.1967, 35, (3), 675-84. Ishak, K.; Baptista, A.; Bianchi, L.; Callea, F.; De Groote, J.; Gudat, F.; Denk, H.; Desmet, V.; Korb, G.; MacSween, R. N.; et al., Histological grading and staging of chronic hepatitis. J Hepatol. 1995, 22, (6), 696-9. Kadiiska, M. B.; Gladen, B. C.; Baird, D. D.; Dikalova, A. E.; Sohal, R. S.; Hatch, G. E.; Jones, D. P.; Mason, R. P.; Barrett, J. C., Biomarkers of oxidative stress study: are plasma antioxidants markers of CCl(4) poisoning? Free Radic Biol Med. 2000, 28, (6), 838-45. Kang, J. H.; Kim, K. S.; Choi, S. Y.; Kwon, H. Y.; Won, M. H.; Kang, T. C., Protective effects of carnosine, homocarnosine and anserine against peroxyl radical-mediated Cu,Zn-superoxide dismutase modification. Biochim Biophys Acta. 2002, 1570, (2), 89-96. Kang, K. S.; Yokozawa, T.; Yamabe, N.; Kim, H. Y.; Park, J. H., ESR study on the structure and hydroxyl radical-scavenging activity relationships of ginsenosides isolated from Panax ginseng C A Meyer. Biol Pharm Bull. 2007, 30, (5), 917-921. Kato, H.; Nakazawa, Y., The effect of carbon tetrachloride on the enzymatic hydrolysis of cellular triglyceride in adult rat hepatocytes in primary monolayer culture. Biochem Pharmacol. 1987, 36, (11), 1807-1814. Karadeniz, A.; Cemek, M.; Simsek, N., The effects of Panax ginseng and Spirulina platensis on hepatotoxicity induced by cadmium in rats. Ecotoxicol Environ Saf. 2009, 72, (1), 231-235. Kemble, R. J.; Glass, H. J.; Hillman, K.; Ratcliffe, B., The protective role of dietary antioxidants (beta-carotene) against free radical formation in anaerobes with continued exposure to oxygen. Cancer Lett. 1997, 114, (1-2), 231-232. Kehrer, J. P., Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol. 1993, 23, (1), 21-48. Knodell, R. G.; Ishak, K. G.; Black, W. C.; Chen, T. S.; Craig, R.; Kaplowitz, N.; Kiernan, T. W.; Wollman, J., Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981, 1, (5), 431-435. Koch, H. P.; Bachner, J.; Loffler, E., Silymarin: potent inhibitor of cyclic AMP phosphodiesterase. Methods Find Exp Clin Pharmacol. 1985, 7, (8), 409-413. Kooij, A., A re-evaluation of the tissue distribution and physiology of xanthine oxidoreductase. Histochem J. 1994, 26, (12), 889-915. Kruidenier, L.; Verspaget, H. W., Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease--radicals or ridiculous? Aliment Pharmacol Ther. 2002, 16, (12), 1997-2015. Kwok, H. H.; Ng, W. Y.; Yang, M. S.; Mak, N. K.; Wong, R. N.; Yue, P. Y., The ginsenoside protopanaxatriol protects endothelial cells from hydrogen peroxide-induced cell injury and cell death by modulating intracellular redox status. Free Radic Biol Med. 48, (3), 437-445. Lawrence, R. A.; Burk, R. F., Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun. 1976, 71, (4), 952-958. Lee, K. S.; Buck, M.; Houglum, K.; Chojkier, M., Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest. 1995, 96, (5), 2461-2468. Lee, Y. T.; Hsu, C. C.; Lin, M. H.; Liu, K. S.; Yin, M. C., Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation. Eur J Pharmacol. 2005a, 513, (1-2), 145-150. Lee, H. U.; Bae, E. A.; Han, M. J.; Kim, N. J.; Kim, D. H., Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury. Liver Int. 2005b, 25, (5), 1069-1073. Lee, H. S.; Keum, K. Y.; Ku, S. K., Effects of Picrorrhiza rhizoma water extracts on the subacute liver damages induced by carbon tetrachloride. J Med Food. 2007, 10, (1), 110-117. Lee, Y. J.; Kim, H. Y.; Kang, K. S.; Lee, J. G.; Yokozawa, T.; Park, J. H., The chemical and hydroxyl radical scavenging activity changes of ginsenoside-Rb1 by heat processing. Bioorg Med Chem Lett. 2008, 18, (16), 4515-4520. Lin, J. M.; Lin, C. C.; Chiu, H. F.; Yang, J. J.; Lee, S. G., Evaluation of the anti-inflammatory and liver-protective effects of anoectochilus formosanus, ganoderma lucidum and gynostemma pentaphyllum in rats. Am J Chin Med. 1993, 21, (1), 59-69. Lin, S. C.; Lin, Y. H.; Chen, C. F.; Chung, C. Y.; Hsu, S. H., The hepatoprotective and therapeutic effects of propolis ethanol extract on chronic alcohol-induced liver injuries. Am J Chin Med. 1997, 25, (3-4), 325-332. Lin, W. C.; Lin, W. L., Ameliorative effect of Ganoderma lucidum on carbon tetrachloride-induced liver fibrosis in rats. World J Gastroenterol. 2006, 12, (2), 265-270. Liu, T. G.; Huang, Y.; Cui, D. D.; Huang, X. B.; Mao, S. H.; Ji, L. L.; Song, H. B.; Yi, C., Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer. 2009, 9, 250. Lockard, V. G.; Mehendale, H. M.; O'Neal, R. M., Chlordecone-induced potentiation of carbon tetrachloride hepatotoxicity: a light and electron microscopic study. Exp Mol Pathol. 1983, 39, (2), 230-245. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J., Protein measurement with the Folin phenol reagent. J Biol Chem. 1951, 193, (1), 265-275. Luper, S., A review of plants used in the treatment of liver disease: part 1. Altern Med Rev. 1998, 3, (6), 410-421. Mannervik, B.; Danielson, U. H., Glutathione transferases--structure and catalytic activity. CRC Crit Rev Biochem. 1988, 23, (3), 283-337. Mates, J. M.; Perez-Gomez, C.; Nunez de Castro, I., Antioxidant enzymes and human diseases. Clin Biochem. 1999, 32, (8), 595-603. Mazur, A.; Nassir, F.; Gueux, E.; Cardot, P.; Bellanger, J.; Lamand, M.; Rayssiguier, Y., The effect of dietary copper on rat plasma apolipoprotein B, E plasma levels, and apolipoprotein gene expression in liver and intestine. Biol Trace Elem Res. 1992, 34, (2), 107-113. Meister, A.; Anderson, M. E., Glutathione. Annu Rev Biochem. 1983, 52, 711-760. Meister, A., Glutathione metabolism and its selective modification. J Biol Chem. 1988, 263, (33), 17205-17208. Melin, A. M.; Perromat, A.; Deleris, G., Pharmacologic application of fourier transform IR spectroscopy: in vivo toxicity of carbon tetrachloride on rat liver. Biopolymers. 2000, 57, (3), 160-168. Mereish, K. A.; Bunner, D. L.; Ragland, D. R.; Creasia, D. A., Protection against microcystin-LR-induced hepatotoxicity by Silymarin: biochemistry, histopathology, and lethality. Pharm Res. 1991, 8, (2), 273-277. Michiels, C.; Raes, M.; Toussaint, O.; Remacle, J., Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med. 1994, 17, (3), 235-248. Moldeus, P.; Jiang, Q. G., Importance of the glutathione cycle in drug metabolism. Pharmacol Ther. 1987, 33, (1), 37-40. Mourelle, M.; Muriel, P.; Favari, L.; Franco, T., Prevention of CCl4-induced liver cirrhosis by silymarin. Fundam Clin Pharmacol. 1989, 3, (3), 183-191. Muriel, P.; Mourelle, M., Prevention by silymarin of membrane alterations in acute CCl4 liver damage. J Appl Toxicol. 1990, 10, (4), 275-279 Naik, S. R.; Panda, V. S., Antioxidant and hepatoprotective effects of Ginkgo biloba phytosomes in carbon tetrachloride-induced liver injury in rodents. Liver Int. 2007, 27, (3), 393-399. Nappi, A. J.; Vass, E., Hydroxyl radical formation resulting from the interaction of nitric oxide and hydrogen peroxide. Biochim Biophys Acta. 1998, 1380, (1), 55-63. Naziroglu, M.; Cay, M.; Ustundag, B.; Aksakal, M.; Yekeler, H., Protective effects of vitamin E on carbon tetrachloride-induced liver damage in rats. Cell Biochem Funct. 1999, 17, (4), 253-259. Neuman, R. E.; Logan, M. A., The determination of hydroxyproline. J Biol Chem. 1950, 184, (1), 299-306. Nieto, N.; Dominguez-Rosales, J. A.; Fontana, L.; Salazar, A.; Armendariz-Borunda, J.; Greenwel, P.; Rojkind, M., Rat hepatic stellate cells contribute to the acute-phase response with increased expression of alpha1(I) and alpha1(IV) collagens, tissue inhibitor of metalloproteinase-1, and matrix-metalloproteinase-2 messenger RNAs. Hepatology. 2001, 33, (3), 597-607. Noctor, G.; Gomez, L.; Vanacker, H.; Foyer, C. H., Interactions between biosynthesis, compartmentation and transport in the control of glutathione homeostasis and signalling. J Exp Bot. 2002, 53, (372), 1283-1304. Ohkawa, H.; Ohishi, N.; Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979, 95, (2), 351-358. Orrenius, S.; McConkey, D. J.; Bellomo, G.; Nicotera, P., Role of Ca2+ in toxic cell killing. Trends Pharmacol Sci. 1989, 10, (7), 281-285. Parola, M.; Leonarduzzi, G.; Biasi, F.; Albano, E.; Biocca, M. E.; Poli, G.; Dianzani, M. U., Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis. Hepatology. 1992, 16, (4), 1014-1021. Peters, T. J.; Neale, G.; Heath, J. R., Effect of bile-duct ligation on organelle marker enzymes in the liver and serum of rats. Clin Sci Mol Med. 1975, 48, (4), 307-313. Poli, G.; Gravela, E.; Albano, E.; Dianzani, M. U., Studies on fatty liver with isolated hepatocytes. II. The action of carbon tetrachloride on lipid peroxidation, protein, and triglyceride synthesis and secretion. Exp Mol Pathol. 1979, 30, (1), 116-127. Pradhan, S. C.; Girish, C., Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res. 2006, 124, (5), 491-504. Pradeep, K.; Mohan, C. V.; Gobianand, K.; Karthikeyan, S., Silymarin modulates the oxidant-antioxidant imbalance during diethylnitrosamine induced oxidative stress in rats. Eur J Pharmacol. 2007, 560, (2-3), 110-116. Rajesh, M. G.; Latha, M. S., Preliminary evaluation of the antihepatotoxic activity of Kamilari, a polyherbal formulation. J Ethnopharmacol. 2004, 91, (1), 99-104. Rahman, Q.; Abidi, P.; Afaq, F.; Schiffmann, D.; Mossman, B. T.; Kamp, D. W.; Athar, M., Glutathione redox system in oxidative lung injury. Crit Rev Toxicol. 1999, 29, (6), 543-568. Ray, L. E.; Prescott, J. M., Isolation and some characteristics of glutathione reductase from rabbit erythrocytes. Proc Soc Exp Biol Med. 1975, 148, (2), 402-409. Recknagel, R. O.; Glende, E. A., Jr.; Dolak, J. A.; Waller, R. L., Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther. 1989, 43, (1), 139-154. Reddy, J. K.; Rao, M. S., Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol. 2006, 290, (5), G852-858. Reed, D. J.; Fariss, M. W., Glutathione depletion and susceptibility. Pharmacol Rev. 1984, 36, (2 Suppl), 25-33. Recknagel, R. O.; Glende, E. A., Jr.; Dolak, J. A.; Waller, R. L., Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther. 1989, 43, (1), 139-154. Reynolds, E. S., Liver Parenchymal Cell Injury. I. Initial Alterations of the cell following poisoning with carbon tetrachloride. J Cell Biol. 1963, 19, 139-157. Saller, R.; Meier, R.; Brignoli, R., The use of silymarin in the treatment of liver diseases. Drugs. 2001, 61, (14), 2035-2063. Sandstrom, J.; Nilsson, P.; Karlsson, K.; Marklund, S. L., 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem. 1994, 269, (29), 19163-19166. Sato, M.; Karasawa, N.; Shimizu, M.; Morimatsu, F.; Yamada, R., Safety evaluation of chicken breast extract containing carnosine and anserine. Food Chem Toxicol. 2008, 46, (2), 480-9. Shukla, R.; Kumar, M., Role of Panax ginseng as an antioxidant after cadmium-induced hepatic injuries. Food Chem Toxicol. 2009, 47, (4), 769-773. Smart, D. E.; Vincent, K. J.; Arthur, M. J.; Eickelberg, O.; Castellazzi, M.; Mann, J.; Mann, D. A., JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 genes in activated hepatic stellate cells. J Biol Chem. 2001, 276, (26), 24414-24421. Smuckler, E. A., Alterations produced in the endoplasmic reticulum by carbon tetrachloride. Panminerva Med. 1976, 18, (9-10), 292-309. Stadtman, E. R.; Oliver, C. N., Metal-catalyzed oxidation of proteins. Physiological consequences. J Biol Chem. 1991, 266, (4), 2005-2008. Sturgill, M. G.; Lambert, G. H., Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function. Clin Chem. 1997, 43, (8 Pt 2), 1512-1526. Sonnenbichler, J.; Goldberg, M.; Hane, L.; Madubunyi, I.; Vogl, S.; Zetl, I., Stimulatory effect of Silibinin on the DNA synthesis in partially hepatectomized rat livers: non-response in hepatoma and other malign cell lines. Biochem Pharmacol. 1986, 35, (3), 538-541. Soskin, S. The liver and carbohydrate metabolism. Endocrinology. 26, 1940, 297-308. Suh, J. H.; Wang, H.; Liu, R. M.; Liu, J.; Hagen, T. M., (R)-alpha-lipoic acid reverses the age-related loss in GSH redox status in post-mitotic tissues: evidence for increased cysteine requirement for GSH synthesis. Arch Biochem Biophys. 2004, 423, (1), 126-135. Sun, Y., Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med. 1990, 8, (6), 583-599. Tateishi, N.; Higashi, T.; Naruse, A.; Nakashima, K.; Shiozaki, H., Rat liver glutathione: possible role as a reservoir of cysteine. J Nutr. 1977, 107, (1), 51-60. Tietze, F., Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969, 27, (3), 502-522. Tirkey, N.; Pilkhwal, S.; Kuhad, A.; Chopra, K., Hesperidin, a citrus bioflavonoid, decreases the oxidative stress produced by carbon tetrachloride in rat liver and kidney. BMC Pharmacol. 2005, 5, 2. Thabrew, M. I.; Joice, P. D.; Rajatissa, W., A comparative study of the efficacy of Pavetta indica and Osbeckia octandra in the treatment of liver dysfunction. Planta Med. 1987, 53, (3), 239-241. Tomasi, A.; Albano, E.; Banni, S.; Botti, B.; Corongiu, F.; Dessi, M. A.; Iannone, A.; Vannini, V.; Dianzani, M. U., Free-radical metabolism of carbon tetrachloride in rat liver mitochondria. A study of the mechanism of activation. Biochem J. 1987, 246, (2), 313-317. Tung, Y. T.; Wu, J. H.; Huang, C. C.; Peng, H. C.; Chen, Y. L.; Yang, S. C.; Chang, S. T., Protective effect of Acacia confusa bark extract and its active compound gallic acid against carbon tetrachloride-induced chronic liver injury in rats. Food Chem Toxicol. 2009, 47, (6), 1385-1392. Turrens, J. F.; Crapo, J. D.; Freeman, B. A., Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J Clin Invest. 1984, 73, (1), 87-95. Uemitsu, N.; Nishimura, C.; Nakayoshi, H., Evaluation of liver weight changes following repeated administration of carbon tetrachloride in rats and body-liver weight relationship. Toxicology. 1986, 40, (2), 181-190. Vaca, C. E.; Wilhelm, J.; Harms-Ringdahl, M., Studies on lipid peroxidation in rat liver nuclei and isolated nuclear membranes. Biochim Biophys Acta. 1988, 958, (3), 375-387. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M. T.; Mazur, M.; Telser, J., Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007, 39, (1), 44-84. Venkataramanan, R.; Komoroski, B.; Strom, S., In vitro and in vivo assessment of herb drug interactions. Life Sci. 2006, 78, (18), 2105-2115. Vienken, J.; Christmann, H., How can liver toxins be removed? Filtration and adsorption with the Prometheus system. Ther Apher Dial. 2006, 10, (2), 125-131. Wagner, H.; Diesel, P.; Seitz, M., [The chemistry and analysis of silymarin from Silybum marianum Gaertn]. Arzneimittelforschung. 1974, 24, (4), 466-471. Wardman, P.; Candeias, L. P., Fenton chemistry: an introduction. Radiat Res. 1996, 145, (5), 523-531. Weber, L. W.; Boll, M.; Stampfl, A., Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol. 2003, 33, (2), 105-136. Weiner, J. A.; Chen, A.; Davis, B. H., E-box-binding repressor is down-regulated in hepatic stellate cells during up-regulation of mannose 6-phosphate/insulin-like growth factor-II receptor expression in early hepatic fibrogenesis. J Biol Chem. 1998, 273, (26), 15913-15919. Weyhenmeyer, R.; Mascher, H.; Birkmayer, J., Study on dose-linearity of the pharmacokinetics of silibinin diastereomers using a new stereospecific assay. Int J Clin Pharmacol Ther Toxicol. 1992, 30, (4), 134-138. Williams, A. T.; Burk, R. F., Carbon tetrachloride hepatotoxicity: an example of free radical-mediated injury. Semin Liver Dis. 1990, 10, (4), 279-284. Xu, T. M.; Cui, M. H.; Xin, Y.; Gu, L. P.; Jiang, X.; Su, M. M.; Wang, D. D.; Wang, W. J., Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis. Chin Med J (Engl). 2008, 121, (15), 1394-1397. Yang, S.; Zhu, H.; Li, Y.; Lin, H.; Gabrielson, K.; Trush, M. A.; Diehl, A. M., Mitochondrial adaptations to obesity-related oxidant stress. Arch Biochem Biophys. 2000, 378, (2), 259-268. Yan, H.; Guo, Y.; Zhang, J.; Ding, Z.; Ha, W.; Harding, J. J., Effect of carnosine, aminoguanidine, and aspirin drops on the prevention of cataracts in diabetic rats. Mol Vis. 2008, 14, 2282-2291. Yang, J. I.; Yoon, J. H.; Bang, Y. J.; Lee, S. H.; Lee, S. M.; Byun, H. J.; Myung, S. J.; Kim, W.; Lee, H. S., Synergistic anti-fibrotic efficacy of statin and protein kinase c inhibitor in hepatic fibrosis. Am J Physiol Gastrointest Liver Physiol. 2009. Yokozawa, T.; Satoh, A.; Cho, E. J., Ginsenoside-Rd attenuates oxidative damage related to aging in senescence-accelerated mice. J Pharm Pharmacol. 2004, 56, (1), 107-113. Yue, P. Y.; Wong, D. Y.; Wu, P. K.; Leung, P. Y.; Mak, N. K.; Yeung, H. W.; Liu, L.; Cai, Z.; Jiang, Z. H.; Fan, T. P.; Wong, R. N., The angiosuppressive effects of 20(R)- ginsenoside Rg3. Biochem Pharmacol. 2006, 72, (4), 437-445. Zimmermann H. J. Experimental hepatotoxicity. In: Eichler O. (Ed.), Handbook of Experimental Pharmacology, 1976, Vol. 16, part 5, Springer, New York, pp. 1-120. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/22314 | - |
| dc.description.abstract | 2008年行政院衛生署所統計之國人十大死因中慢性肝炎及肝硬化排名第七位，顯示肝病之防治及治療為目前台灣急需改善之健康議題。本實驗之主要目的是以四氯化碳 (carbon tetrachloride, CCl4)誘導急性及慢性肝損傷動物實驗模式評估人參雞精 (ginseng-based chicken essence, GCE)之護肝保健功效。急性實驗將Wistar大鼠分成六組，分別為控制組、四氯化碳組、Silymarin 正控制組 (0.5 g/kg bw/day)、低、中及高劑量人參雞精樣品 (0.62、3.12和6.23 g/kg bw/day)組。各組經過連續5天管餵0.5%羧甲基纖維素 (carboxymethyl cellulose, CMC)、Silymarin (0.5 g/kg bw/day)或低、中及高劑量人參雞精樣品 (0.62、3.12和6.23 g/kg bw/day)後，各組於第六天腹腔注射四氯化碳 (40% CCl4 in olive oil，1 ml/kg bw)經18小時後犧牲，採集血液並剖腹取肝臟樣本進行分析。實驗結果顯示，在血清中丙胺酸轉胺酶 (alanine aminotransferase, ALT)和天門冬胺酸轉胺酶 (aspartate aminotransferase, AST)值方面，三種劑量人參雞精樣品組皆低於四氯化碳組，而以高劑量人參雞精樣品 (6.23 g/kg bw/day)組達顯著降低的情形 (p < 0.05)。在抗氧化及解毒代謝酵素及抗氧化物質方面，四氯化碳會顯著降低肝臟中抗氧化物質麩胱甘肽 (glutathione, GSH)含量 (p < 0.05)，且降低肝臟中抗氧化及解毒代謝酵素如麩胱甘肽過氧化酶 (glutathione peroxidase, GPx)、麩胱甘肽還原酶 (glutathione reductase, GRd)、麩胱甘肽硫轉移酶 (glutathione S-transferase, GST)、過氧化氫酶 (catalase, CAT)、及超氧化物歧化酶 (superoxide dismutase, SOD)等酵素活性，而人參雞精樣品則能顯著改善上述情形 (p < 0.05)。急性實驗以中劑量人參雞精樣品 (3.12 g/kg bw/day)組對改善四氯化碳所誘導之肝損傷效果最具顯著。而在慢性實驗中，四氯化碳組改以管餵 (20% CCl4 in olive oil，1.5 ml/kg bw)每週管餵兩次，連續進行八週；每日經口給予0.5% CMC、Silymarin或低、中及高劑量人參雞精樣品 (0.62、3.12和6.23 g/kg bw/day)八週後，進行犧牲並採集血液及肝臟樣品作為分析之用。慢性實驗結果顯示，四氯化碳組會較正常大鼠顯著增加肝臟之相對重量 (p < 0.05)，而給予人參雞精樣品可顯著改善四氯化碳組肝臟之相對重量增加現象 (p < 0.05)；給予低、中及高劑量人參雞精樣品 (0.62、3.12和6.23 g/kg bw/day)較四氯化碳組顯著降低ALT、AST值 (p < 0.05)；此外，給予低、中及高劑量人參雞精 (0.62、3.12和6.23 g/kg bw/day)的組別較四氯化碳組可顯著增加大鼠肝臟中還原態GSH含量，及肝臟GPx、GRd、GST、CAT及SOD酵素活性情形 (p < 0.05)；此外人參雞精樣品亦可改善四氯化碳所造成肝臟中脂質過氧化物硫代巴比妥酸反應物質 (thiobarbituric acid reactive substances, TBARS)及羥脯胺酸 (hydroxyproline)等含量增加的情形 (p < 0.05)。低劑量人參雞精樣品 (0.62 g/kg bw/day)組即具有顯著改善四氯化碳所誘發之肝損傷情形。因此，綜合以上急性及慢性實驗結果，在四氯化碳所誘導肝損傷模式下，本實驗之人參雞精樣品的確具有護肝功效之潛力。 | zh_TW |
| dc.description.abstract | According to the statistics data of Department of Health Executive Yuan of Taiwan, chronic liver disease and cirrhosis is the seventh leading cause of death in Taiwan in 2008. Preventing and treating liver disease is a public health problem in Taiwan. The aim of this study was to evaluate the hepatoprotective effect of ginseng-based chicken essence (GCE) on carbon tetrachloride (CCl4)-induced acute and chronic liver injuries in rats. In acute experiment, male Wistar rats were randomly divided into six groups: control, CCl4, CCl4 + 0.5 g Silymarin/kg bw/day, CCl4 + 0.62 g GCE/kg bw/day, CCl4 + 3.12 g GCE/kg bw/day, and CCl4 + 6.23 g GCE/kg bw/day. Rats were orally administrated 0.5% carboxymethyl cellulose (CMC), Silymarin, or GCE for consecutive 5 days. After CCl4 (40% in olive oil, 1 ml/kg bw) was intraperitoneally injection on 6th day, rats were sacrificed after 18 hours, and the blood and liver sample were taken for analysis. Compared to CCl4 group, GCE at 6.23 g/kg bw/day showed significant decrease in ALT and AST levels (p < 0.05). The results of hepatic reduced GSH content, antioxidation and detoxification enzyme activities indaicated that CCl4 could significantly lower hepatic GSH, and decrease the activities of glutathione peroxidase (GPx), glutathione reductase (GRd), glutathione S-transferase (GST), catalase (CAT), and superoxide dismutase (SOD) compared to control group (p < 0.05), however, GCE significantly recovered them (p < 0.05). 6.23 g GCE/kg bw/day exhibited significantly protective effects on CCl4-induced acute liver injury in rats. In chronic experiment, liver injury was induced by oral administration with CCl4 (20% in olive oil, 1.5 ml/kg bw), twice a week for 8 weeks. After oral administration of 0.5% CMC, Silymarin or GCE for 8 weeks, rats were sacrificed, and their blood and liver samples were collected for further analysis. The results showed that CCl4 administration could significantly increased liver relative weights compared with the normal control group (p < 0.05), and rats administrated with GCE showed significantly decreased liver relative weights compared with CCl4 group (p < 0.05). Compared to CCl4 groups, oral administration GCE at 0.62 g, 3.12 g, and 6.23 g/kg bw significantly recovered AST and ALT level (p < 0.05), and significantly increased hepatic GSH content, and enzyme activities of GPx, GRd, GST, CAT, and SOD (p < 0.05). Furthermore, GCE treatment could significantly lower the accumulation of hepatic thiobarbituric acid reactive substances (TBARS) and hydroxyproline caused by CCl4 treatment (p < 0.05). The chronic experiment results indicated that 0.62 g GCE/kg bw/day could significantly recover the liver injury caused by CCl4. Based on the results of acute and chronic experiments, GCE samples probably could exert a potential hepatoprotective effects against CCl4-induced liver injury models. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-08T04:15:23Z (GMT). No. of bitstreams: 1 ntu-99-R96641037-1.pdf: 1293729 bytes, checksum: c83ae74676c09337776bc22950544f06 (MD5) Previous issue date: 2010 | en |
| dc.description.tableofcontents | 中文摘要 I
英文摘要 III 目錄 V 圖次 VIII 表次 IX 中英文對照表 XI 第一章、前言 1 第二章、文獻回顧 3 第一節、肝臟之簡介 3 一、肝臟之組織結構 3 二、肝臟之生理功能 4 三、肝臟疾病之簡介 6 第二節、活性氧屬簡介 7 一、ROS之種類及生成 7 二、ROS與脂質過氧化物之相關性 10 三、ROS相關疾病 12 第三節、人體抗氧化防禦系統 13 一、酵素性抗氧化系統 13 二、非酵素性抗氧化系統 16 第四節、四氯化碳 18 第五節、水飛薊素之護肝功效 20 第六節、本實驗使用之中草藥複方簡介 22 一、雞精 (chicken essence) 22 二、人參 (Panax ginseng) 25 第三章、實驗架構 27 第一節、急性實驗架構 27 第二節、慢性實驗架構 28 第四章、材料與方法 29 第一節、實驗材料 29 第二節、四氯化碳誘導肝損傷之動物模式 31 第三節、實驗動物分析方法 34 第五章 結果 40 第一節、急性實驗結果 40 一、人參雞精對四氯化碳誘導大鼠急性肝損傷之肝臟、脾臟和腎臟相對重量之變化 40 二、人參雞精對四氯化碳誘導大鼠急性肝損傷之血清中丙胺酸轉胺酶及天門冬胺酸轉胺酶生化值之影響 41 三、人參雞精對四氯化碳誘導大鼠急性肝損傷肝臟中還原態麩胱甘肽之影響 41 四、人參雞精對四氯化碳誘導大鼠急性肝損傷之肝臟中抗氧化酵素麩胱 甘肽過氧化酶之影響 42 五、人參雞精對四氯化碳誘導大鼠急性肝損傷之肝臟中抗氧化酵素麩胱甘肽還原酶之影響 42 六、人參雞精對四氯化碳誘導大鼠急性肝損傷之肝臟中抗氧化酵素麩胱甘肽硫轉移酶之影響 43 七、人參雞精對四氯化碳誘導大鼠急性肝損傷之肝臟中抗氧化酵素過氧化氫酶之影響 43 八、人參雞精對四氯化碳誘導大鼠急性肝損傷之肝臟中抗氧化酵素超氧化物歧化酶之影響 44 九、人參雞精對四氯化碳誘導大鼠急性肝損傷之血清及肝臟中三酸甘油酯和總膽固醇之影響 44 第二節、慢性實驗結果 46 一、人參雞精對四氯化碳誘導大鼠慢性肝損傷體重變化之影響 46 二、人參雞精對四氯化碳誘導大鼠慢性肝損傷之肝臟、脾臟和腎臟相對重量之變化 46 三、人參雞精對四氯化碳誘導大鼠慢性肝損傷之血清中丙胺酸轉胺酶之影響 47 四、人參雞精對四氯化碳誘導大鼠慢性肝損傷之血清中天門冬胺酸轉胺酶之影響 47 五、人參雞精對四氯化碳誘導大鼠慢性肝損傷之肝臟中還原態麩胱甘肽之影響 48 六、人參雞精對四氯化碳誘導大鼠慢性肝損傷之肝臟中抗氧化酵素麩胱甘肽過氧化酶之影響 48 七、人參雞精對四氯化碳誘導大鼠慢性肝損傷之肝臟中抗氧化酵素麩胱甘肽還原酶之影響 49 八、人參雞精對四氯化碳誘導大鼠慢性肝損傷之肝臟中抗氧化酵素麩胱甘肽硫轉移酶之影響 49 九、人參雞精對四氯化碳誘導大鼠慢性肝損傷之肝臟中抗氧化酵素麩胱過氧化氫酶之影響 50 十、人參雞精對四氯化碳誘導大鼠慢性肝損傷之肝臟中抗氧化酵素超氧化物歧化酶之影響 50 十一、人參雞精對四氯化碳誘導大鼠慢性肝損傷之血清中三酸甘油酯之影響 51 十二、人參雞精對四氯化碳誘導大鼠慢性肝損傷血清中總膽固醇之影 響 51 十三、人參雞精對四氯化碳誘導大鼠慢性肝損傷之肝臟中三酸甘油酯和總膽固醇之影響 51 十四、人參雞精對四氯化碳誘導大鼠慢性肝損傷之肝臟中脂質過氧化物之影響 52 十五、人參雞精對四氯化碳誘導大鼠慢性肝損傷之肝臟中之羥脯胺酸含量之影響 52 十六、人參雞精對四氯化碳誘導大鼠慢性肝損傷之慢性實驗肝纖維化病理評估之影響 53 第六章 討論 54 一、人參雞精對四氯化碳誘導大鼠慢性肝損傷所造成體重之變化情形 54 二、人參雞精對四氯化碳誘導大鼠急性及慢性肝損傷所造成肝臟、脾臟和腎臟相對重量變化 54 三、人參雞精對四氯化碳誘導大鼠急性及慢性肝損傷所造成血清中丙胺酸轉胺酶及天門冬胺酸轉胺酶生化值之影響 55 四、人參雞精對四氯化碳誘導大鼠急性及慢性肝損傷所造成血清及肝臟中三酸甘油酯和總膽固醇之變化 57 五、人參雞精對四氯化碳誘導大鼠慢性肝損傷所造成肝臟中脂質過氧化物之影響 57 六、人參雞精對四氯化碳誘導大鼠急性及慢性肝損傷所造成肝臟中抗氧化物質及抗氧化酵素之影響 58 七、人參雞精對四氯化碳誘導大鼠慢性肝損傷所造成肝臟中羥輔胺酸之影響 60 八、人參雞精對四氯化碳誘導大鼠慢性肝損傷所造成慢性實驗肝纖維化病理評估之影響 61 第七章 結論 62 第八章 結果圖表 63 第九章 參考文獻 84 圖次 圖一 ROS與脂質過氧化物的形成路徑 11 圖二 四氯化碳之代謝途徑 19 圖三 人參雞精對四氯化碳誘導大鼠急性肝損傷之組織病理切片圖 (HE stain, 200X) 70 圖四 人參雞精對四氯化碳誘導大鼠慢性肝損傷之組織病理切片圖 (HE stain, 200X) 82 圖五 人參雞精對四氯化碳誘導大鼠慢性肝損傷之組織病理切片圖 (Masson’s trichrome stain, 200X) 83 附圖一 人參雞精對四氯化碳誘導大鼠急性肝損傷之組織病理切片圖 (HE stain, 100X) 96 附圖二 人參雞精對四氯化碳誘導大鼠慢性肝損傷之組織病理切片圖 (HE stain, 100X) 97 附圖三 人參雞精對四氯化碳誘導大鼠慢性肝損傷之組織病理切片圖 (Masson’s trichrome stain, 100X) 98 表次 表一 氧化壓力所造成體內主要組成成份之傷害 8 表二 氧化壓力相關之疾病 12 表三 大鼠管餵劑量 30 表四 人參雞精對四氯化碳誘導大鼠急性肝損傷之肝臟、脾臟和腎臟相對重量之變化 63 表五 人參雞精對四氯化碳誘導大鼠急性肝損傷之血清中丙胺酸轉胺酶及天門冬胺酸轉胺酶生化值之影響 64 表六 人參雞精對四氯化碳誘導大鼠急性肝損傷肝臟中還原態麩胱甘肽之影響 65 表七 人參雞精對四氯化碳誘導大鼠急性肝損傷之肝臟中抗氧化酵素麩胱甘肽過氧化酶、麩胱甘肽還原酶及麩胱甘肽硫轉移酶之影響 66 表八 人參雞精對四氯化碳誘導大鼠急性肝損傷之肝臟中抗氧化酵素過氧化氫酶和超氧化物歧化酶之影響 67 表九 人參雞精對四氯化碳誘導大鼠急性肝損傷之血清中三酸甘油酯和總膽固醇之影響 68 表十 人參雞精對四氯化碳誘導大鼠急性肝損傷之肝臟中三酸甘油酯和總膽固醇之影響 69 表十一 人參雞精對四氯化碳誘導大鼠慢性肝損傷體重變化之影響 71 表十二 人參雞精對四氯化碳誘導大鼠慢性肝損傷之肝臟、脾臟和腎臟相對重量之變化 72 表十三 人參雞精對四氯化碳誘導大鼠慢性肝損傷之血清中丙胺酸轉胺酶之影響 73 表十四 人參雞精對四氯化碳誘導大鼠慢性肝損傷之血清中天門冬胺酸轉胺酶之影響 74 表十五 人參雞精對四氯化碳誘導大鼠慢性肝損傷之肝臟中還原態麩胱甘肽之影響 75 表十六 人參雞精對四氯化碳誘導大鼠慢性肝損傷之肝臟中抗氧化酵素麩胱甘肽過氧化酶、麩胱甘肽還原酶及麩胱甘肽硫轉移酶之影響 76 表十七 人參雞精對四氯化碳誘導大鼠慢性肝損傷之肝臟中抗氧化酵素麩胱過氧化氫酶和超氧化物歧化酶之影響 77 表十八 人參雞精對四氯化碳誘導大鼠慢性肝損傷之血清中三酸甘油酯和總膽固醇之影響 78 表十九 人參雞精對四氯化碳誘導大鼠慢性肝損傷之肝臟中三酸甘油酯和總膽固醇之影響 79 表二十 人參雞精對四氯化碳誘導大鼠慢性肝損傷之肝臟中脂質過氧化物和羥輔胺酸含量之影響 80 表二十一 人參雞精對四氯化碳誘導大鼠慢性肝損傷之慢性實驗肝纖維化病理評估之影響 81 | |
| dc.language.iso | zh-TW | |
| dc.subject | 四氯化碳 | zh_TW |
| dc.subject | 抗氧化 | zh_TW |
| dc.subject | 護肝功效 | zh_TW |
| dc.subject | 保健食品 | zh_TW |
| dc.subject | 肝損傷 | zh_TW |
| dc.subject | 人參雞精 | zh_TW |
| dc.subject | hepatoprotective effect | en |
| dc.subject | carbon tetrachloride | en |
| dc.subject | ginseng-based chicken essence | en |
| dc.subject | health foods | en |
| dc.subject | liver injury | en |
| dc.subject | antioxidation and detoxification enzymes | en |
| dc.title | 以四氯化碳誘導大鼠肝損傷模式評估人參雞精食療方之護肝保健功效 | zh_TW |
| dc.title | Evaluation of hepatic protection of ginseng-based chicken essence against CCl4-induced
liver oxidative injury of rat | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 98-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 邱智賢,謝明哲(Ming-Jer Hsieh),鍾景光,李宗貴 | |
| dc.subject.keyword | 四氯化碳,人參雞精,保健食品,肝損傷,抗氧化,護肝功效, | zh_TW |
| dc.subject.keyword | carbon tetrachloride,ginseng-based chicken essence,health foods,liver injury,antioxidation and detoxification enzymes,hepatoprotective effect, | en |
| dc.relation.page | 98 | |
| dc.rights.note | 未授權 | |
| dc.date.accepted | 2010-08-08 | |
| dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
| dc.contributor.author-dept | 食品科技研究所 | zh_TW |
| 顯示於系所單位： | 食品科技研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-99-1.pdf 未授權公開取用 | 1.26 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。